Population Pharmacokinetics and Exposure-Response Analyses of an MDM2 Inhibitor Milademetan

被引：0
|
作者：
Kang, Dongwoo [1 ]
Kumar, Prasanna [1 ]
Zernovak, Oleg [1 ]
Song, Saeheum [1 ]
Xiong, Yuan [2 ]
Bergsma, Tim [2 ]
Lovern, Mark [2 ]
Yin, Ophelia [1 ]
机构：
[1] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[2] Certara, Princeton, NJ USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-045
引用
下载
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [11] Population Pharmacokinetics and Exposure-Response Analyses for CPX-351 in Patients With Hematologic Malignancies
    Wang, Qi
    Banerjee, Kamalika
    Vasilinin, Grygoriy
    Marier, J. F.
    Gibbons, Jacqueline A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (05): : 748 - 762
  • [12] Population pharmacokinetics and exposure-response analyses for efficacy and safety of apadacitinib in patients with axial Spondyloarthritis
    Bhatnagar, Sumit
    Eckert, Doerthe
    Stodtmann, Sven
    Song, In-Ho
    Wung, Peter
    Liu, Wei
    Mohamed, Mohamed-Eslam F.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (02):
  • [13] Population Pharmacokinetics and Exposure-Response Analysis of Entospletinib, a Selective Spleen Tyrosine Kinase Inhibitor
    Sharma, Shringi
    Jin, Feng
    He, Jing
    Robeson, Michelle
    Abella, Esteban
    Sharman, Jeff P.
    Ramanathan, Srini
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S79 - S79
  • [14] Population Pharmacokinetics and Exposure-Response of Albinterferon Alfa-2B
    Riggs, Matthew M.
    Bergsma, Timothy T.
    Rogers, J.
    Gastonguay, Marc
    Subramanian, Mani
    Chen, C.
    Devalaraja, M.
    Corey, A.
    GASTROENTEROLOGY, 2010, 138 (05) : S848 - S848
  • [15] Population Pharmacokinetics and Exposure-Response of Albinterferon Alfa-2b
    Riggs, Matthew M.
    Bergsma, Timothy T.
    Rogers, James A.
    Gastonguay, Marc R.
    Subramanian, G. Mani
    Chen, Cecil
    Devalaraja, Matt
    Corey, Alfred E.
    Sun, Haiying
    Yu, Jing
    Stein, Daniel S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (04): : 475 - 486
  • [16] POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE OF ALBINTERFERON ALFA-2B
    Riggs, M.
    Bergsma, T.
    Rogers, J.
    Gastonguay, M.
    Subramanian, G.
    Chen, C.
    Devalaraja, M.
    Corey, A.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S123 - S124
  • [17] POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE ANALYSES CONFIRM THE ALECTINIB 600 MG BID DOSE IN THE GLOBAL ALK INHIBITOR-NAIVE POPULATION.
    Hsu, J. C.
    Jaminion, F.
    Guerini, E.
    Nueesch, E.
    Balas, B.
    Zeaiter, A.
    Morcos, P. N.
    Frey, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S69 - S69
  • [18] Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome
    Marier, Jean-Francois
    Jomphe, Claudia
    Peyret, Thomas
    Wang, Yi
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (06): : 2497 - 2509
  • [19] Population pharmacokinetics and exposure-response analyses of trastuzumab in patients with advanced gastric or gastroesophageal junction cancer
    Cosson, Valerie F.
    Ng, Vivian W.
    Lehle, Michaela
    Lum, Bert L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 737 - 747
  • [20] Population Pharmacokinetics and Exposure-Response Analyses to Guide Dosing of Icatibant in Pediatric Patients With Hereditary Angioedema
    Wang, Yi
    Jomphe, Claudia
    Marier, Jean-Francois
    Martin, Patrick
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (04): : 555 - 564
12345